Tag Archives: LivaNova PLC

Analysts Offer Insights on Healthcare Companies: LivaNova PLC (NASDAQ: LIVN), Quidel Corp (NASDAQ: QDEL) and ACADIA Pharmaceuticals Inc (NASDAQ: ACAD)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on LivaNova PLC (LIVN – Research Report), Quidel Corp (QDEL – Research Report) and ACADIA Pharmaceuticals Inc (ACAD – Research Report) with bullish

LivaNova PLC (LIVN) Receives a Buy from Berenberg Bank

In a report issued on September 6, Scott Bardo from Berenberg Bank maintained a Buy rating on LivaNova PLC (LIVN – Research Report), with a price target of $114. The company’s shares closed last Monday at $80.53. Bardo has an

LivaNova PLC (LIVN) Gets a Buy Rating from Needham

In a report released today, Michael Matson from Needham reiterated a Buy rating on LivaNova PLC (LIVN – Research Report), with a price target of $91. The company’s shares closed last Monday at $79.68. According to TipRanks.com, Matson is a

Needham Thinks LivaNova PLC’s Stock is Going to Recover

Needham analyst Michael Matson maintained a Buy rating on LivaNova PLC (LIVN – Research Report) today and set a price target of $87. The company’s shares closed on Friday at $72.27, close to its 52-week low of $64.80. According to

Needham Remains a Buy on LivaNova PLC (LIVN)

In a report released today, Michael Matson from Needham reiterated a Buy rating on LivaNova PLC (LIVN – Research Report), with a price target of $87. The company’s shares closed yesterday at $71.70, close to its 52-week low of $64.80.

LivaNova PLC (LIVN) Receives a Hold from BTIG

In a report released yesterday, Sean Lavin from BTIG reiterated a Hold rating on LivaNova PLC (LIVN – Research Report). The company’s shares closed yesterday at $68.55, close to its 52-week low of $64.80. Lavin noted: “As expected, LIVN revised